Skip to content

Study · Non-randomized trial · 1984

1 result

[Use of a thymus polypeptide preparation to diagnose and correct immune deficiency states in multiple sclerosis].

Golovkin VI, Ankhimova ES, Morozov VG, Khavinson VG

Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952)1 Jan 1984

PMID6201026 (opens in a new tab)PepBankPUB-06201026
Publisher pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In patients with disseminated sclerosis, thymaline treatment produced positive clinical and immunological results without specific outcome details.

    In plain wordsIn patients with disseminated sclerosis, thymaline produced positive clinical and immune results, but the abstract did not specify the outcomes.

    Peptide
    Thymalin
    Outcome
    Direction not reportedClinical and immunological results
    Study

    n: not reported in source

    Outcome group
    Immune response · Whole body
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Clinical and immunological results turned out positive.
    2 context sentences
    Summary · context
    Thymus-dependent immunity as well as thymic factor and corticosteroid influence upon it were studied in 36 patients with disseminated sclerosis.
    Summary · context
    The Soviet drug thymaline, obtained from calf thymus, was first used for the treatment of disseminated sclerosis.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.